181 related articles for article (PubMed ID: 32506194)
21. Diagnostic Limitation of Fine-Needle Aspiration (FNA) on Indeterminate Thyroid Nodules Can Be Partially Overcome by Preoperative Molecular Analysis: Assessment of RET/PTC1 Rearrangement in BRAF and RAS Wild-Type Routine Air-Dried FNA Specimens.
Ko YS; Hwang TS; Kim JY; Choi YL; Lee SE; Han HS; Kim WS; Kim SK; Park KS
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417935
[TBL] [Abstract][Full Text] [Related]
22. Performance of a dual-component molecular assay in cytologically indeterminate thyroid nodules.
Sponziello M; Brunelli C; Verrienti A; Grani G; Pecce V; Abballe L; Ramundo V; Damante G; Russo D; Lombardi CP; Durante C; Rossi ED; Straccia P; Fadda G; Filetti S
Endocrine; 2020 May; 68(2):458-465. PubMed ID: 32232767
[TBL] [Abstract][Full Text] [Related]
23. Multicentre validation of a microRNA-based assay for diagnosing indeterminate thyroid nodules utilising fine needle aspirate smears.
Lithwick-Yanai G; Dromi N; Shtabsky A; Morgenstern S; Strenov Y; Feinmesser M; Kravtsov V; Leon ME; Hajdúch M; Ali SZ; VandenBussche CJ; Zhang X; Leider-Trejo L; Zubkov A; Vorobyov S; Kushnir M; Goren Y; Tabak S; Kadosh E; Benjamin H; Schnitzer-Perlman T; Marmor H; Motin M; Lebanony D; Kredo-Russo S; Mitchell H; Noller M; Smith A; Dattner O; Ashkenazi K; Sanden M; Berlin KA; Bar D; Meiri E
J Clin Pathol; 2017 Jun; 70(6):500-507. PubMed ID: 27798083
[TBL] [Abstract][Full Text] [Related]
24. [The value of multi-gene testing in benign or malign diagnosis of thyroid nodules with indeterminate cytology].
Song YT; Xu GH; Zhu YL; Ma TH; Yu H; Wang TX; Yu WB; Wei W; Zhang B
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Oct; 54(10):764-768. PubMed ID: 31606990
[No Abstract] [Full Text] [Related]
25. Highly Sensitive and Specific Molecular Test for Mutations in the Diagnosis of Thyroid Nodules: A Prospective Study of
Cho YY; Park SY; Shin JH; Oh YL; Choe JH; Kim JH; Kim JS; Yim HS; Kim YL; Ki CS; Kim TH; Chung JH; Kim SW
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781560
[TBL] [Abstract][Full Text] [Related]
26. FNA smears as a potential source of DNA for targeted next-generation sequencing of lung adenocarcinomas.
Treece AL; Montgomery ND; Patel NM; Civalier CJ; Dodd LG; Gulley ML; Booker JK; Weck KE
Cancer Cytopathol; 2016 Jun; 124(6):406-14. PubMed ID: 26882436
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic performance of next-generation sequencing and genetic profiling in thyroid nodules from a single center in China.
Ren M; Yao Q; Bao L; Wang Z; Wei R; Bai Q; Ping B; Chang C; Wang Y; Zhou X; Zhu X
Eur Thyroid J; 2022 May; 11(3):. PubMed ID: 35521779
[TBL] [Abstract][Full Text] [Related]
28. EGFR mutational genotyping of liquid based cytology samples obtained via fine needle aspiration (FNA) at endobronchial ultrasound of non-small cell lung cancer (NSCLC).
Reynolds JP; Tubbs RR; Minca EC; MacNamara S; Almeida FA; Ma PC; Pennell NA; Cicenia JC
Lung Cancer; 2014 Nov; 86(2):158-63. PubMed ID: 25263855
[TBL] [Abstract][Full Text] [Related]
29. Centralized molecular testing for oncogenic gene mutations complements the local cytopathologic diagnosis of thyroid nodules.
Beaudenon-Huibregtse S; Alexander EK; Guttler RB; Hershman JM; Babu V; Blevins TC; Moore P; Andruss B; Labourier E
Thyroid; 2014 Oct; 24(10):1479-87. PubMed ID: 24811481
[TBL] [Abstract][Full Text] [Related]
30. Impact of molecular screening for point mutations and rearrangements in routine air-dried fine-needle aspiration samples of thyroid nodules.
Eszlinger M; Krogdahl A; Münz S; Rehfeld C; Precht Jensen EM; Ferraz C; Bösenberg E; Drieschner N; Scholz M; Hegedüs L; Paschke R
Thyroid; 2014 Feb; 24(2):305-13. PubMed ID: 23837487
[TBL] [Abstract][Full Text] [Related]
31. The Role of Molecular Testing for the Indeterminate Thyroid FNA.
Rossi ED; Pantanowitz L; Faquin WC
Genes (Basel); 2019 Sep; 10(10):. PubMed ID: 31547603
[TBL] [Abstract][Full Text] [Related]
32. Comparison of cytocentrifugation supernatant fluid and formalin-fixed paraffin-embedded tissue for targeted next-generation sequencing.
Janaki N; Harbhajanka A; Michael CW; Bomeisl P; Wasman J; Atchley M; Miskiewicz K; Alouani D; Sadri N
Cancer Cytopathol; 2019 May; 127(5):297-305. PubMed ID: 30933438
[TBL] [Abstract][Full Text] [Related]
33. Next-generation sequencing in thyroid cancer.
Cha YJ; Koo JS
J Transl Med; 2016 Nov; 14(1):322. PubMed ID: 27871285
[TBL] [Abstract][Full Text] [Related]
34. BRAF V600E mutation analysis of thyroid nodules needle aspirates in relation to their ultrasongraphic classification: a potential guide for selection of samples for molecular analysis.
Nam SY; Han BK; Ko EY; Kang SS; Hahn SY; Hwang JY; Nam MY; Kim JW; Chung JH; Oh YL; Shin JH
Thyroid; 2010 Mar; 20(3):273-9. PubMed ID: 20187782
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic value and lymph node metastasis prediction of a custom‑made panel (thyroline) in thyroid cancer.
Ke Z; Liu Y; Zhang Y; Li J; Kuang M; Peng S; Liang J; Yu S; Su L; Chen L; Sun C; Li B; Cao J; Lv W; Xiao H
Oncol Rep; 2018 Aug; 40(2):659-668. PubMed ID: 29901149
[TBL] [Abstract][Full Text] [Related]
36. Lung adenocarcinoma and its thyroid metastasis characterized on fine-needle aspirates by cytomorphology, immunocytochemistry, and next-generation sequencing.
Bellevicine C; Vigliar E; Malapelle U; Carelli E; Fiorelli A; Vicidomini G; Cappabianca S; Santini M; Troncone G
Diagn Cytopathol; 2015 Jul; 43(7):585-9. PubMed ID: 25900221
[TBL] [Abstract][Full Text] [Related]
37. A multiplex technology platform for the rapid analysis of clinically actionable genetic alterations and validation for BRAF p.V600E detection in 1549 cytologic and histologic specimens.
Smith DL; Lamy A; Beaudenon-Huibregtse S; Sesboüé R; Laosinchai-Wolf W; Sabourin JC; Labourier E
Arch Pathol Lab Med; 2014 Mar; 138(3):371-8. PubMed ID: 23808402
[TBL] [Abstract][Full Text] [Related]
38. Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies.
Houghton J; Hadd AG; Zeigler R; Haynes BC; Latham GJ
J Vis Exp; 2016 Apr; (110):e53836. PubMed ID: 27166994
[TBL] [Abstract][Full Text] [Related]
39. Performance validation of an amplicon-based targeted next-generation sequencing assay and mutation profiling of 648 Chinese colorectal cancer patients.
Wang Y; Liu H; Hou Y; Zhou X; Liang L; Zhang Z; Shi H; Xu S; Hu P; Zheng Z; Liu R; Tang T; Ye F; Liang Z; Bu H
Virchows Arch; 2018 Jun; 472(6):959-968. PubMed ID: 29705968
[TBL] [Abstract][Full Text] [Related]
40. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules.
Nikiforov YE; Steward DL; Robinson-Smith TM; Haugen BR; Klopper JP; Zhu Z; Fagin JA; Falciglia M; Weber K; Nikiforova MN
J Clin Endocrinol Metab; 2009 Jun; 94(6):2092-8. PubMed ID: 19318445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
